A review of human carcinogens--Part B: biological agents

scientific article (publication date: April 2009)

A review of human carcinogens--Part B: biological agents is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1470-2045(09)70096-8
P3181OpenCitations bibliographic resource ID32399
P698PubMed publication ID19350698

P50authorYann GrosseQ63681468
Kurt StraifQ63701596
Lamia Benbrahim-TallaaQ52563483
Neela GuhaQ54263882
Béatrice Lauby-SecretanQ56816033
P2093author name stringFreeman C
Bouvard V
Baan R
Guha N
Cogliano V
El Ghissassi F
Galichet L
P2860cites workClassification of papillomavirusesQ29618731
Antibodies against human herpesvirus 8 in black South African patients with cancer.Q33864971
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adultsQ33925343
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohortsQ34340678
Helicobacter pylori and esophageal cancer risk: a meta-analysisQ36410246
Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinomaQ37212310
The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in UgandaQ38883642
Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.Q40006257
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infectionQ43038794
Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast ThailandQ46547825
Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.Q54638403
Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in KoreaQ57212941
A review of human carcinogens—Part A: pharmaceuticalsQ58006583
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)321-2
P577publication date2009-04-01
P1433published inLancet Oncology CommissionQ13747613
P1476titleA review of human carcinogens--Part B: biological agents
P478volume10

Reverse relations

cites work (P2860)
Q401964435azadC treatment upregulates miR-375 level and represses HPV16 E6 expression
Q385862579-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Q496876339-Valent human papillomavirus vaccine: a review of the clinical development program.
Q36734588A Community-Based Approach to Enhancing Anal Cancer Screening in Hawaii's HIV-Infected Ethnic Minorities
Q38780225A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa
Q36169189A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia
Q36407125A Suggested Approach to Simplify and Improve Cervical Screening in the United States
Q86927860A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents
Q59357534A bacterial genotoxin causes virus reactivation and genomic instability in Epstein-Barr virus infected epithelial cells pointing to a role of co-infection in viral oncogenesis
Q38378838A cohort study of cervical screening using partial HPV typing and cytology triage
Q34442596A combination of the Kato-Katz methods and ELISA to improve the diagnosis of clonorchiasis in an endemic area, China
Q36514226A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men.
Q35671337A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil
Q34580264A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years
Q61774978A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L
Q41715956A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: the largest registry-based study to date
Q34153680A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection
Q35164373A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study
Q35630020A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent?
Q39236598A mutagenesis method for the addition and deletion of highly repetitive DNA regions: the paradigm of EPIYA motifs in the cagA gene of Helicobacter pylori
Q40458264A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site.
Q64076777A novel sequencing-based vaginal health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis
Q33793914A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia
Q35154570A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers.
Q34708325A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls
Q36427451A review of methods for detect human Papillomavirus infection
Q36016617A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results
Q41524569A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity
Q30368719A tegument-specific venom allergen-like protein of Clonorchis sinensis.
Q92369502A virome-wide clonal integration analysis platform for discovering cancer viral etiology
Q27346723AACR Cancer Progress Report 2014
Q37210896AACR Cancer Progress Report 2015
Q47150003Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala
Q37275408Accuracy of the Kato-Katz method and formalin-ether concentration technique for the diagnosis of Clonorchis sinensis, and implication for assessing drug efficacy
Q42146528Acetylation of intragenic histones on HPV16 correlates with enhanced HPV16 gene expression
Q38863335Addressing the Barriers to Cervical Cancer Prevention Among Hispanic Women
Q28544831Advanced enzymology, expression profile and immune response of Clonorchis sinensis hexokinase show its application potential for prevention and control of clonorchiasis
Q35039759Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection
Q35858231Alcohol Drinking Obliterates the Inverse Association Between Serum Retinol and Risk of Head and Neck Cancer
Q34577067Allergies and risk of head and neck cancer: an original study plus meta-analysis
Q38947049An EF-handed Ca(2+)-binding protein of Chinese liver fluke Clonorchis sinensis
Q64386288An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening
Q37180056An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study
Q27014019An updated overview of HPV-associated head and neck carcinomas
Q40126055Anal HPV 16 and 18 viral load: a comparison between HIV-negative and HIV-positive MSM and association with persistence
Q89430566Anal HPV infection and correlates in HIV-infected patients attending a Sexually Transmitted Infection clinic in Brazil
Q37996691Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis
Q92446826Analysis of Human Papillomavirus (HPV) 16 Variants Associated with Cervical Infection in Italian Women
Q38754272Analysis of Multiple HPV E6 PDZ Interactions Defines Type-Specific PDZ Fingerprints That Predict Oncogenic Potential
Q90865025Analytical performance evaluation of the HPV OncoCheck assay for detection of high-risk HPV infection in liquid-based cervical samples
Q47727139Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer
Q30534669Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels
Q47134134Anogenital Human Papillomavirus Infection and HIV Infection Outcomes Among Peruvian Transgender Women: Results from a Cohort Study
Q26777623Antibiotic treatment for Helicobacter pylori: Is the end coming?
Q35623269Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study
Q60947009Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis
Q44320296Application of a loop-mediated isothermal amplification (LAMP) assay targeting cox1 gene for the detection of Clonorchis sinensis in human fecal samples
Q34596772Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer
Q41153416Are male immigrants in Denmark at lower or higher risk of tobacco-related cancers? A Danish nationwide cohort study
Q40727294Assessing Acceptability of Self-Sampling Kits, Prevalence, and Risk Factors for Human Papillomavirus Infection in American Indian Women
Q98183610Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixed-genotype biopsy specimens using laser capture microdissection as the reference standard
Q90696421Assessment of control strategies against Clonorchis sinensis infection based on a multi-group dynamic transmission model
Q52631128Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing.
Q36904250Association Between Cumulative Psychosocial Risk and Cervical Human Papillomavirus Infection Among Female Adolescents in a Free Vaccination Program
Q41294071Association Between Educational Level and Risk of Cancer in HIV-infected Individuals and the Background Population: Population-based Cohort Study 1995-2011.
Q39974039Association Between Serum 25-Hydroxyvitamin D Level and Human Papillomavirus Cervicovaginal Infection in Women in the United States
Q37570000Association Between Type-specific HPV Infections and hTERT DNA Methylation in Patients with Invasive Cervical Cancer.
Q91708310Association Study Between Methylation in the Promoter Regions of cGAS, MAVS, and TRAF3 Genes and the Risk of Cervical Precancerous Lesions and Cervical Cancer in a Southern Chinese Population
Q42374973Association between four SNPs in IL-4 and the risk of gastric cancer in a Chinese population
Q35203345Association between free testosterone levels and anal human papillomavirus types 16/18 infections in a cohort of men who have sex with men
Q36253519Association between hTERT activation by HPV E6 proteins and oncogenic risk
Q35328464Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda
Q88585888Association between the XPG gene rs2094258 polymorphism and risk of gastric cancer
Q37524425Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study
Q33526682Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers
Q36405118Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy
Q26782217Association of Lymphomagenesis and the Reactivation of Hepatitis B Virus in Non-Hodgkin Lymphoma
Q41487050Association of human papillomavirus type 58 with breast cancer in Shaanxi province of China
Q37077419Association of human papillomavirus, Neisseria gonorrhoeae and Chlamydia trachomatis co-infections on the risk of high-grade squamous intraepithelial cervical lesion
Q52665346Association of marijuana use with oral HPV infection and periodontitis among Hispanic adults: Implications for oral cancer prevention.
Q36319807Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa
Q54363768Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia risk.
Q37838503Asymptomatic anal sexually transmitted infections in HIV-positive men attending anal cancer screening
Q30746365Autonomous portable solar ultraviolet spectroradiometer (APSUS) - a new CCD spectrometer system for localized, real-time solar ultraviolet (280-400 nm) radiation measurement
Q37430038Awareness and knowledge of Human Papillomavirus (HPV), HPV-related cancers, and HPV vaccines in an uninsured adult clinic population
Q28554487Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function
Q33798426BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV.
Q35571682Banking on the future: biobanking for "omics" approaches to biomarker discovery for Opisthorchis-induced cholangiocarcinoma in Thailand
Q91650119Beta HPV Type 15 Can Interfere With NF-κB Activity and Apoptosis in Human Keratinocytes
Q55279812Beta and gamma human papillomaviruses in anal and genital sites among men: prevalence and determinants.
Q38365921Beta genus papillomaviruses and skin cancer.
Q43428036Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients
Q36344288Beyond tobacco in head and neck squamous cell cancers… Emerging era of molecular targeted therapy and virtual biopsy
Q57061702Bile acids drive chemotaxis of Clonorchis sinensis juveniles to the bile duct
Q91655554Bioinformatics analysis of key biomarkers and pathways in KSHV infected endothelial cells
Q35870615Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response?
Q89052830Biotransformation of benzo[a]pyrene by the thermophilic bacterium Bacillus licheniformis M2-7
Q61058238Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
Q35642804Breastfeeding and Helicobacter pylori Infection in Early Childhood: a Continuing Dilemma
Q35949799Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action
Q60925276Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea
Q36629357Burden of cervical, anal, and oral HPV in an inner-city pre-vaccine adolescent population
Q37160564C3H/He Mice as an Incompatible Cholangiocarcinoma Model by Clonorchis sinensis, Dicyclanil and N-Nitrosodimethylamine
Q36720252CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study
Q37327810CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis
Q36407727Can clinical tests help monitor human papillomavirus vaccine impact?
Q34011249Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis
Q92138425Cancer Incidence among Healthcare Workers in Cancer Centers: A 14-Year Retrospective Cohort Study in Thailand
Q36859850Cancer Mortality Projections in Korea up to 2032.
Q92306506Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications
Q38609576Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.
Q51350011Cancer mortality in India: a nationally representative survey.
Q34991464Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions.
Q91945356Cancers attributable to infections in Canada
Q44863515Carcinogenic human papillomavirus infection
Q92995485Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea
Q34320412Carcinogenic viruses and solid cancers without sufficient evidence of causal association.
Q48009574Carcinogenicity of malaria and of some polyomaviruses
Q34522328Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis
Q36421345Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial
Q33888215Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia
Q36187634Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test
Q42261545Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells.
Q40359221Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort.
Q47380141Cervical cancer screening uptake among HIV-positive women in Ontario, Canada: A population-based retrospective cohort study
Q41644873Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme.
Q54901443Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice.
Q38180277Cervical cancer screening: on the way to a shift from cytology to full molecular screening
Q34441738Cervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa.
Q33894231Cervical human papillomavirus detection is not affected by menstrual phase
Q28729883Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations
Q30244338Changing epidemiology of Helicobacter pylori in Japan
Q34059657Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
Q38119854Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea
Q44325641Characteristics of HPV infection over time in European women who are HIV-1 positive
Q36735676Characterization of Intra-Type Variants of Oncogenic Human Papillomaviruses by Next-Generation Deep Sequencing of the E6/E7 Region
Q33979909Characterization of a novel cutaneous human papillomavirus genotype HPV-125
Q54985457Characterization of a novel organic solute transporter homologue from Clonorchis sinensis.
Q90106891Characterization of the hepatitis C virus epidemic in Pakistan
Q37997368Characterization of the human papillomavirus (HPV) integration sites into genital cancers
Q47548612Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions
Q35867432Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer
Q33678275Chronic inflammation and cytokines in the tumor microenvironment
Q48134092Cigarette Smoking Promotes Infection of Cervical Cells by High-Risk Human Papillomaviruses, but not Subsequent E7 Oncoprotein Expression
Q92568546Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis
Q37006487Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection
Q37223983Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
Q58749448Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework
Q47599053Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples
Q35036033Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control
Q37065936Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up
Q30651813Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study
Q37628825Clinical validation of AdvanSure GenoBlot assay as primary screening and test of cure for human papillomavirus infection
Q37757640Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology
Q59800056Clinical validation of the Cervista high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study
Q33969398Cloning, expression, and characterization of a novel Opisthorchis viverrini calcium-binding EF-hand protein
Q33890090ClonorESTdb: a comprehensive database for Clonorchis sinensis EST sequences
Q38571961Clonorchiasis
Q34212501Clonorchiasis control: starting from awareness
Q92605389Clonorchis sinensis MF6p/HDM (CsMF6p/HDM) induces pro-inflammatory immune response in RAW 264.7 macrophage cells via NF-κB-dependent MAPK pathways
Q36204682Clonorchis sinensis excretory/secretory products promote the secretion of TNF-alpha in the mouse intrahepatic biliary epithelial cells via Toll-like receptor 4.
Q40085464Clonorchis sinensis infection and co-infection with the hepatitis B virus are important factors associated with cholangiocarcinoma and hepatocellular carcinoma
Q26315335Clonorchis sinensis omega-class glutathione transferases play major roles in the protection of the reproductive system during maturation and the response to oxidative stress
Q40873145Clonorchis sinensis ova in bile juice cytology from a patient with severe hyperbilirubinemia and portal vein thrombosis
Q34534207Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review
Q35093306Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica
Q91709724Co-prevalence of human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar
Q33745553Codon Usage Patterns of Tyrosinase Genes in Clonorchis sinensis
Q37800921Commercially available assays for multiplex detection of alpha human papillomaviruses
Q33798276Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma
Q38119752Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study
Q54377217Comparative evaluation of different DNA extraction methods for HPV genotyping by linear array and INNO-LiPA.
Q50073530Comparative evaluation of the Omniplex-HPV and RFMP HPV PapilloTyper for detecting human papillomavirus genotypes in cervical specimens.
Q34938697Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies
Q38844434Comparison of GeneFinder human papillomavirus (HPV) Liquid Beads Microarray PCR Kit and Hybrid Capture 2 Assay for Detection of HPV Infection.
Q36256554Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years).
Q58792602Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure
Q40264939Comparison of anal HPV natural history among men by country of residence: Brazil, Mexico, and the United States.
Q35342179Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study
Q35066980Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.
Q41284477Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
Q38402711Comparison of cobas human papillomavirus test results from primary versus secondary vials of PreservCyt specimens and evaluation of potential cross-contamination
Q40694854Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening.
Q42375482Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay
Q46555447Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo.
Q34055574Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions
Q92628871Comparison of nylon-flocked swab and Dacron swab cytology for anal HSIL detection in transgender women and gay, bisexual, and other men who have sex with men
Q36118559Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
Q35943033Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population.
Q40226418Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States.
Q33807593Comparison of the digene HPV genotyping LQ test and the PANArray HPV genotyping chip for detection of high-risk or probable high-risk human papillomavirus genotypes
Q41633856Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology
Q33859491Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian Women
Q42246317Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma
Q37566932Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women
Q38674506Concordance of HPV load and HPV mRNA for 16 carcinogenic/possibly carcinogenic HPV types in paired smear/tissue cervical cancer specimens.
Q38184467Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies
Q64081988Connexin 43 plays an important role in the transformation of cholangiocytes with Clonochis sinensis excretory-secretory protein and N-nitrosodimethylamine
Q36974955Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study.
Q33863292Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy
Q40709573Control of HPV-associated cancers with HPV vaccination
Q40364663Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention
Q57222529Control of clonorchiasis in Korea: effectiveness of health education for community leaders and individuals in an endemic area
Q45189964Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.
Q99637347Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: an observational cohort study
Q30275666Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study
Q44350321Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Q36083187Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
Q29353702Cross-sectional study of genital carcinogenic HPV infections in Paramaribo, Suriname: prevalence and determinants in an ethnically diverse population of women in a pre-vaccination era.
Q36677322Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic
Q58803075Cs1, a Clonorchis sinensis-derived serodiagnostic antigen containing tandem repeats and a signal peptide
Q34588285Culture for genetic manipulation of developmental stages of Schistosoma mansoni
Q61806398Culture of fecal indicator bacteria from snail intestinal tubes as a tool for assessing the risk of Opisthorchis viverrini infection in Bithynia snail habitat
Q36656216Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia
Q57173901Current high prevalences of Strongyloides stercoralis and Opisthorchis viverrini infections in rural communities in northeast Thailand and associated risk factors
Q40056541Current status and future prospects for human papillomavirus vaccines
Q26744209Current status and perspectives of Clonorchis sinensis and clonorchiasis: epidemiology, pathogenesis, omics, prevention and control
Q37030691Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle
Q37018430Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study
Q40612174Cutaneous human papillomavirus genotypes in different kinds of skin lesions in Argentina
Q30409315Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study
Q93026339Cyclohexane-1,3-dione as a derivatizing agent for the analysis of aldehydes by micelar electrokinetic chromatography with diode array detection
Q90164614Cytokine Production in Cholangiocarcinoma Cells in Response to Clonorchis sinensis Excretory-Secretory Products and Their Putative Protein Components
Q49890881DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
Q43857210De novo malignant disease after liver transplantation? Risk and surveillance strategies
Q39068018De novo thyroid cancer following solid organ transplantation-A 25-year experience at a high-volume institution with a review of the literature.
Q30685686Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
Q28548445Degradation of Human PDZ-Proteins by Human Alphapapillomaviruses Represents an Evolutionary Adaptation to a Novel Cellular Niche
Q40075938Degradation of cofilin is regulated by Cbl, AIP4 and Syk resulting in increased migration of LMP2A positive nasopharyngeal carcinoma cells
Q28475532Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity
Q33935272Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea.
Q92714674Detection and genotyping of human papillomavirus virus (HPV): a comparative analysis of clinical performance in cervical and urine samples in Chilean women
Q35489644Detection of Clonorchis sinensis circulating antigen in sera from Chinese patients by immunomagnetic bead ELISA based on IgY.
Q36970051Detection of Human Papillomavirus 16-Specific IgG and IgM Antibodies in Patient Sera: A Potential Indicator of Oral Squamous Cell Carcinoma Risk Factor
Q93382452Detection of human papillomavirus 67 single infection in high-grade cervical lesions: Case report and review of literature
Q36890494Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancer
Q90721452Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing
Q51171929Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
Q36565494Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women
Q34315668Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis
Q36826712Development and characterization of the cobas human papillomavirus test
Q47149093Development and implementation of a system for the early identification of emerging risks in food and feed
Q35834831Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads
Q37726438Development of a polymerase chain reaction applicable to rapid and sensitive detection of Clonorchis sinensis eggs in human stool samples
Q28478834Developmental transcriptomic features of the carcinogenic liver fluke, Clonorchis sinensis
Q90594835Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma
Q42206121Diagnostic accuracy of colposcopy in relation to human papillomavirus genotypes and multiple infection
Q38842960Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells.
Q28383010Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium
Q36474916Dietary glycemic load, glycemic index, and carbohydrates on the risk of primary liver cancer among Chinese women and men.
Q47266595Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
Q37363392Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
Q36205419Differential Protein Expression in the Hemolymph of Bithynia siamensis goniomphalos Infected with Opisthorchis viverrini.
Q34734252Differential activation of diverse glutathione transferases of Clonorchis sinensis in response to the host bile and oxidative stressors
Q33846801Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.
Q44399871Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011.
Q34105234Disability weight of Clonorchis sinensis infection: captured from community study and model simulation
Q37496183Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening
Q29353543Distinctive distribution of HPV genotypes in cervical cancers in multi-ethnic Suriname: implications for prevention and vaccination
Q40129728Distribution and attribution of high-risk human papillomavirus genotypes in cervical precancerous lesions in China
Q35685061Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women
Q38984023Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women
Q46208405Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women
Q39745725Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion
Q57089348Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada
Q42260259Distribution of human papillomavirus genotypes, assessment of HPV 16 and 18 viral load and anal related lesions in HIV positive patients: a cross-sectional analysis
Q36769394Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya
Q40681570Diversity of beta-papillomavirus at anogenital and oral anatomic sites of men: The HIM Study.
Q38963668Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?
Q91632927Downregulation of RAGE Inhibits Cell Proliferation and Induces Apoptosis via Regulation of PI3K/AKT Pathway in Cervical Squamous Cell Carcinoma
Q57089344Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec
Q41929232Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
Q57044322Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study
Q37718767Dynamics of high-risk nonvaccine human papillomavirus types after actual vaccination scheme
Q45391153E6 and E7 variants of human papillomavirus-16 and -52 in Japan, the Philippines, and Vietnam
Q39378537Early detection and estimation of infection burden by real-time PCR in rats experimentally infected with Clonorchis sinensis.
Q28472903Effect of control strategies on prevalence, incidence and re-infection of clonorchiasis in endemic areas of China
Q35871517Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer
Q33647741Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study
Q90711625Effect of weighting for sampling and non-response on estimates of STI prevalence in the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3)
Q50065432Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions.
Q41051528Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study
Q43267321Efficacy of artesunate and artemether against Clonorchis sinensis in rabbits
Q94539195Efficient production of HPV16 E2 protein from HPV16 late mRNAs spliced from SD880 to SA2709
Q40877197Egg-specific expression of protein with DNA methyltransferase activity in the biocarcinogenic liver fluke Clonorchis sinensis
Q37642847Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease
Q56904286Emerging and re-emerging infectious disease in otorhinolaryngology
Q38319580Environmental (nongenetic) factors in gynecological cancers: update and future perspectives
Q37078556Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination
Q34182283Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China
Q49265752Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening.
Q57922398Epidemiology and biology of cutaneous human papillomavirus
Q37727399Epidemiology of cervical cancer in Colombia
Q42690821Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women
Q37669732Epidemiology of oral human papillomavirus infection
Q35841460Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain.
Q55346681Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.
Q37314766Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58.
Q90481228Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans
Q90483607Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland
Q35125635Epstein-Barr virus microRNAs and lung cancer.
Q40108143Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.
Q55312268Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.
Q28076178Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors
Q90630982Estimating incidence rates of grouped HPV types: A systematic review and comparison of the impact of different epidemiological assumptions
Q26781786Estimation of Cancer Burden Attributable to Infection in Asia
Q34493286Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact
Q37888518Estimation of cancer cases and deaths attributable to infection in China
Q41056813Ethnic and geographic variations in HPV prevalence and genotype distribution in north-western Yunnan, China
Q55097392European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination.
Q39620969Evaluation of carcinogenic hazard of diesel engine exhaust needs to consider revolutionary changes in diesel technology
Q31083741Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma
Q35282198Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination
Q37004759Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer
Q36511847Evaluation of the management of Hr-HPV+/PapTest- women: results at 1-year recall
Q47714066Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies
Q36949283Evolution of human papillomavirus carcinogenicity
Q38114642Evolution of the papillomaviridae
Q45765408Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: a model-based approach
Q55234256Exposure to Antineoplastic Agents Induces Cytotoxicity in Nurse Lymphocytes: Role of Mitochondrial Damage and Oxidative Stress.
Q28266917Exposure to Bovine Leukemia Virus Is Associated with Breast Cancer: A Case-Control Study
Q48785791Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type.
Q46604994Extended Middle East and North Africa: cervical cancer and human papillomavirus: can we make the case for prevention in this "relatively" low prevalence region?
Q38949757Extracellular calcium regulates keratinocyte proliferation and HPV 16 E6 RNA expression in vitro.
Q38684508Extrahepatic manifestations of HCV: the role of direct acting antivirals
Q35053172Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM).
Q57034643Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women
Q86657082Factors associated with human papillomavirus infection among women in the Northwest Territories
Q37620568Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers
Q64089921False positive cervical HPV screening test results
Q36541982Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
Q34433015Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer
Q28287720Food-borne trematodiases in Southeast Asia epidemiology, pathology, clinical manifestation and control
Q56762499Frequency and coinfection between genotypes of human papillomavirus in a population of asymptomatic women in northern Peru
Q36055770Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study
Q36255382Full-length single-cell RNA-seq applied to a viral human cancer: applications to HPV expression and splicing analysis in HeLa S3 cells
Q28078631Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites
Q34363927Functional analysis of Kaposi's sarcoma-associated herpesvirus vFLIP expression reveals a new mode of IRES-mediated translation
Q37403181Functional genes and proteins of Clonorchis sinensis
Q43745960Functional polymorphism rs4072037 in MUC1 gene contributes to the susceptibility to gastric cancer: evidence from pooled 6,580 cases and 10,324 controls
Q36180589Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology.
Q59357086Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV
Q33600457Gastric Cancer in the Era of Precision Medicine
Q35480890Gastric cancer epidemiology in Korea
Q34194651Gastric cancer: an infectious disease
Q59361031Generation of a novel next-generation sequencing-based method for the isolation of new human papillomavirus types
Q35530646Generic microtiter plate assay for triaging clinical specimens prior to genotyping of human papillomavirus DNA via consensus PCR.
Q38376969Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study
Q34056375Genetic manipulation of Schistosoma haematobium, the neglected schistosome.
Q30279220Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study.
Q36376205Genital human papillomavirus (HPV) concordance in heterosexual couples.
Q35463790Genital transmission of human papillomavirus in recently formed heterosexual couples
Q37461632Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer
Q35680789Genome-wide characterization of microsatellites and marker development in the carcinogenic liver fluke Clonorchis sinensis
Q36432579Genomic polymorphism of human papillomavirus type 52 in women from Northeast China
Q43849421Genotoxicity induced by Taenia solium and its reduction by immunization with calreticulin in a hamster model of taeniosis.
Q39775493Genotypes distribution of human papillomavirus in cervical samples of Ecuadorian women
Q35141881Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs
Q39393413Genotypic prevalence of human papillomavirus infection during normal pregnancy: a cross-sectional study
Q40892448German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment
Q37069804Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences
Q29620303Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
Q34620280Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010
Q39484712Global burden of food-borne trematodiasis
Q37959784Global burden of human food-borne trematodiasis: a systematic review and meta-analysis
Q38064060Global burden of human papillomavirus and related diseases.
Q22241238Global cancer statistics
Q33744003Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences
Q35971370Grand challenges in cancer epidemiology and prevention
Q37082877Gut bacteria and cancer
Q35592111Gut bacteria require neutrophils to promote mammary tumorigenesis
Q35987613H. pylori vaccines: why we still don't have any
Q44317446HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV.
Q36675916HIV Infection Alters the Spectrum of HPV Subtypes Found in Cervical Smears and Carcinomas from Kenyan Women
Q37214352HIV and HPV infections and ocular surface squamous neoplasia: systematic review and meta-analysis.
Q35031952HIV associated high-risk HPV infection among Nigerian women.
Q90646260HIV modifies the effect of tobacco smoking on oral human papillomavirus infection
Q38149333HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers
Q89666353HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review
Q36240830HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India
Q35908027HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
Q89834860HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?
Q58994032HPV Prevalence and Detection of Rare HPV Genotypes in Hong Kong Women from Southern China with Cytological Abnormalities
Q40211544HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL.
Q41045517HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region
Q37144878HPV and oral lesions: preventive possibilities, vaccines and early diagnosis of malignant lesions
Q34157209HPV catch-up vaccination of young women: a systematic review and meta-analysis
Q36888568HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ test.
Q57193588HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia
Q31121182HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data
Q34313933HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India
Q50044506HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.
Q34485433HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong province, China: a cross-sectional study
Q40643444HPV genotypes detected in the oropharyngeal mucosa of HIV-infected men who have sex with men in Northern Italy.
Q49907625HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.
Q46699275HPV in urology. Basic principles and controversies
Q36746765HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?
Q34983800HPV prevalence among women from Appalachia: results from the CARE project
Q61447073HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory
Q34006684HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system
Q42203937HPV prevalence and type distribution in women with normal or abnormal Pap smear in Bulgaria
Q34618650HPV testing by cobas HPV test in a population from Catalonia
Q64054260HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
Q36480261HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies.
Q57494504HPV vaccination is fundamental for reducing or erradicate penile cancer | Opinion: NO
Q35441106HPV-16 impairs the subcellular distribution and levels of expression of protein phosphatase 1γ in cervical malignancy
Q40396965HPV-6 Molecular Variants Association With the Development of Genital Warts in Men: The HIM Study
Q36856284HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease
Q35598917HPV-induced anal lesions
Q30580161HPV-related cancers after solid organ transplantation in the United States
Q30252655HPV-related external genital lesions among men residing in Brazil
Q36901882HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study
Q40693093HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women
Q54242431HTLV-1 Alters T Cells for Viral Persistence and Transmission.
Q56984609Harnessing Genomic Technologies to Explore the Molecular Biology of Liver Flukes-Major Implications for Fundamental and Applied Research
Q35858737Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa
Q34612386HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model
Q35172224Helicobacter pylori Infection and Gastric Adenocarcinoma.
Q37350096Helminth infection in southern Laos: high prevalence and low awareness
Q34128439Helminths in human carcinogenesis
Q40110872Hepatic iron overload is associated with hepatocyte apoptosis during Clonorchis sinensis infection
Q45323588Hepatitis B virus X protein inhibits apoptosis by modulating endoplasmic reticulum stress response
Q45367473Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan
Q34106504Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Q38607430Hepatitis C Virus Genotypes in the Middle East and North Africa: Distribution, Diversity, and Patterns
Q34101320Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index
Q26750997Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?
Q38163597Hepatocellular carcinoma and cholangiocarcinoma: an update
Q26750646Hepatocellular carcinoma and the risk of occupational exposure
Q35756750Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma
Q35860988Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing
Q34268415Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study
Q30206108High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial
Q43469953High HPV infection prevalence in men from infertile couples and lack of relationship between seminal HPV infection and sperm quality.
Q58604536High Prevalence of Human Papillomavirus Types 56 and 70 Identified in the Native Populations of Sabah, Malaysia
Q30383606High Toxoplasma gondii Seropositivity among Brain Tumor Patients in Korea.
Q40117867High diversity of alpha, beta and gamma human papillomaviruses in genital samples from HIV-negative and HIV-positive heterosexual South African men.
Q36607257High frequency of human papillomavirus detection in the vagina before first vaginal intercourse among females enrolled in a longitudinal cohort study
Q34694485High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study
Q47559002High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns
Q37030821High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects
Q97549213High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China
Q64359199High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad
Q46576040High prevalence of human papillomavirus infection in Eastern European and West African women immigrants in South Italy
Q93099597High prevalence of human papillomavirus infection in HIV-infected women living in French Antilles and French Guiana
Q35418185High risk human papillomavirus persistence among HIV-infected young women in South Africa
Q97645835High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions
Q35619059High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey
Q64241375High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance
Q36559876High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner
Q91592321High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
Q37187658Higher prevalence and gene amplification of HPV16 in oropharynx as compared to oral cavity
Q51773647Highlights of the 26th international papillomavirus conference and workshops.
Q34160028Histopathological diagnosis of opisthorchiasis in an immigrant
Q56959696Hookworm exposure decreases human papillomavirus uptake and cervical cancer cell migration through systemic regulation of epithelial-mesenchymal transition marker expression
Q55112573Host chemokine signature as a biomarker for the detection of pre-cancerous cervical lesions.
Q28069401Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine
Q99711630How Can Gene-Expression Information Improve Prognostic Prediction in TCGA Cancers: An Empirical Comparison Study on Regularization and Mixed Cox Models
Q51587656How do snails meet fish? Landscape perspective needed to study parasite prevalence.
Q92128486Human DNA Virus Exploitation of the MAPK-ERK Cascade
Q40056132Human Immunodeficiency Virus Status Differentially Associated With Genital and Anal Human Papillomavirus Infection Among Chinese Men Who Have Sex With Men: A Cross-Sectional Survey
Q55239038Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.
Q45357821Human Papilloma Virus infection in sexually active adolescent girls
Q36466049Human Papillomavirus (HPV) Genotyping: Automation and Application in Routine Laboratory Testing
Q47664629Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity
Q33740118Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage.
Q35898888Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
Q90454830Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients
Q89620954Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Q37594497Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy
Q36675236Human Papillomavirus Laboratory Testing: the Changing Paradigm
Q53548285Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Q64254644Human Papillomavirus infection in senegalese female sex workers
Q35729429Human U6 promoter drives stronger shRNA activity than its schistosome orthologue in Schistosoma mansoni and human fibrosarcoma cells
Q36262929Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?
Q39049854Human liver flukes
Q64090225Human liver flukes in China and ASEAN: Time to fight together
Q61448596Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins
Q47555534Human papilloma virus: An etiological and prognostic factor for oral cancer?
Q34487394Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix
Q35867881Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix
Q44413201Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
Q37826532Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix
Q35051454Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California
Q33774640Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types
Q47599124Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study
Q37700184Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer
Q28659720Human papillomavirus 45 genetic variation and cervical cancer risk worldwide
Q37481203Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
Q35677956Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies.
Q42217974Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy
Q90001554Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response
Q27023127Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts
Q38064067Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis
Q28069930Human papillomavirus and gastrointestinal cancer: A review
Q35144254Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study
Q55287837Human papillomavirus clustering patterns among HIV-infected and HIV-uninfected adolescent females in South Africa.
Q27026226Human papillomavirus genome variants
Q49476041Human papillomavirus genotype affects metastatic rate following radiotherapy in patients with uterine cervical cancer.
Q36509823Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men
Q45206974Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Q51426652Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males.
Q47621642Human papillomavirus genotype distribution among HPV-positive women in Sichuan province, Southwest China
Q47548474Human papillomavirus genotype distribution in cervical cancer biopsies from Nepalese women
Q36358126Human papillomavirus genotypes among women with or without HIV infection: an epidemiological study of Moroccan women from the Souss area
Q34536611Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta
Q34863458Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil
Q44252736Human papillomavirus genotypes distribution in cervical samples from Uruguayan women
Q33984185Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3
Q92039393Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana
Q36131433Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico
Q47128102Human papillomavirus in semen and the risk for male infertility: a systematic review and meta-analysis
Q34903696Human papillomavirus in the lesions of the oral mucosa according to topography.
Q42244723Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India
Q40107289Human papillomavirus infection among male clients of female sex workers soliciting sex in brothels in Peru
Q33630795Human papillomavirus infection and squamous cell carcinoma of the conjunctiva
Q41747762Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirus-associated Bowen disease
Q42270400Human papillomavirus infection in women in four regions of Senegal
Q34471165Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria
Q42206744Human papillomavirus infection requires the TSG101 component of the ESCRT machinery
Q41465634Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specific prevalence and HPV coinfections
Q37257349Human papillomavirus molecular biology and disease association
Q42277972Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa
Q35821601Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status
Q41651390Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
Q37909359Human papillomavirus testing and genotyping in cervical screening
Q34997580Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review
Q34616083Human papillomavirus testing in the prevention of cervical cancer
Q39477130Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial
Q58794974Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1β
Q34116193Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage
Q40892020Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia
Q42262648Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia
Q37309275Human papillomavirus types distribution in organised cervical cancer screening in France
Q58452367Human papillomavirus vaccination for men: advancing policy and practice
Q35558593Human papillomavirus vaccination: current indications and future directions
Q38218612Human papillomavirus vaccination: where are we now?
Q37762242Human papillomavirus vaccines: current status and future prospects
Q36417526Human papillomavirus variants among Inuit women in northern Quebec, Canada
Q37631295Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
Q37901056Human papillomavirus: science and technologies for the elimination of cervical cancer
Q36545311Human papillomavirus: what every provider should know.
Q93025985Human papillomaviruses 16 and 58 are distributed widely among women living in Shanghai, China, with high-grade, squamous intraepithelial lesions
Q38026999Human papillomaviruses and the specificity of PDZ domain targeting.
Q46344926Human tumour viruses and the deregulation of cell polarity in cancer
Q37711147Human viral oncogenesis: a cancer hallmarks analysis
Q54266087Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components.
Q39909954Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities.
Q51546154Identification and biochemical characterization of two novel peroxiredoxins in a liver fluke, Clonorchis sinensis.
Q34052874Identification and characterization of a novel 21.6-kDa tegumental protein from Clonorchis sinensis
Q47427658Identification and characterization of myophilin-like protein: a life stage and tissue-specific antigen of Clonorchis sinensis
Q44063748Identification and characterization of the second cysteine protease inhibitor of Clonorchis sinensis (CsStefin-2).
Q35262229Identification and molecular characterization of Parkin in Clonorchis sinensis
Q33908196Identification of G protein-coupled receptors in Schistosoma haematobium and S. mansoni by comparative genomics
Q31048577Identification of Known and Novel Recurrent Viral Sequences in Data from Multiple Patients and Multiple Cancers
Q41713745Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II.
Q49438443Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database.
Q40117225Identifying Helminth Infections via Routine Fecal Parasitological Examinations in Korea
Q37416397Identifying molecular drivers of gastric cancer through next-generation sequencing
Q38853095Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection
Q97436156Immediate histologic correlation in women with atypical squamous cells of undetermined significance cytology and positive high-risk HPV: A retrospective review of 6000 cases in a large academic women's hospital
Q92151588Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice
Q37092377Immunization and challenge shown by hamsters infected with Opisthorchis viverrini following exposure to gamma-irradiated metacercariae of this carcinogenic liver fluke.
Q64280722Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses
Q41136544Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa
Q35818624Immunologic Control of Mus musculus Papillomavirus Type 1.
Q40045752Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy
Q35044376Immunoprevention of human papillomavirus-associated malignancies
Q37371401Impact of HPV infection on the development of head and neck cancer
Q40571982Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study.
Q42209167Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer
Q33883581Impact of improved classification on the association of human papillomavirus with cervical precancer
Q45358139Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea
Q92030460Importance of the immune system in head and neck cancer
Q91735602Improving diagnostic performance of the Kato-Katz method for Clonorchis sinensis infection through multiple samples
Q36445316In vitro maintenance of Clonorchis sinensis adult worms
Q21558774Inactivation of p53 rescues the maintenance of high risk HPV DNA genomes deficient in expression of E6
Q37524405Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.
Q38215252Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages
Q36201512Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection
Q40138686Incidence and risk factors for human papillomavirus infections in young female online daters.
Q64111789Incidence and time trends of anal cancer among people living with HIV in Australia
Q39229572Incidence of Endemic Burkitt Lymphoma in Three Regions of Mozambique
Q36915102Incidence, Duration, Persistence, and Factors Associated With High-risk Anal Human Papillomavirus Persistence Among HIV-negative Men Who Have Sex With Men: A Multinational Study
Q40743154Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years
Q35037011Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States
Q33936349Increased all-cause and cancer mortality in HTLV-II infection.
Q89590945Increasing Cervical Cancer Incidence in Rural Eastern Cape Province of South Africa From 1998 to 2012: A Population-Based Cancer Registry Study
Q33574454Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions
Q38956930Induction of cancer-related microRNA expression profiling using excretory-secretory products of Clonorchis sinensis
Q26863592Infection and cancer in multicellular organisms
Q48043820Infection with high-risk HPV types among female sex workers in northern Vietnam
Q27692556Infection with the carcinogenic human liver fluke, Opisthorchis viverrini
Q34909875Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome.
Q38906518Infection-related and -unrelated malignancies, HIV and the aging population
Q33642185Infections and Follicular Lymphoma: is there a Link?
Q36843283Infections and cancer: debate about using vaccines as a cancer control tool
Q90731772Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu
Q35249205Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans
Q33762765Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa
Q36970255Influence of oxidation and multimerization on the immunogenicity of a thioredoxin-l2 prophylactic papillomavirus vaccine
Q34192784Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study
Q92585765Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancer
Q28731860Insights into SCP/TAPS proteins of liver flukes based on large-scale bioinformatic analyses of sequence datasets
Q39807848Integrating novel primary- and secondary-prevention strategies: the next challenge for cervical cancer control
Q34360414InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions
Q39090529Interaction of HPV E6 oncoproteins with specific proteasomal subunits
Q36138481Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways
Q85597772Interactions between E6AP and E6 proteins from alpha and beta HPV types
Q59351027Interfacing Pathogen Detection with Smartphones for Point-of-Care Applications
Q39241651International trends in anal cancer incidence rates
Q34989590Interplay between DNA repair and inflammation, and the link to cancer
Q42283899Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan
Q33682928Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
Q42650234Investigating Canadian parents' HPV vaccine knowledge, attitudes and behaviour: a study protocol for a longitudinal national online survey
Q40117840Investigating the role of human papillomavirus in lung cancer
Q38833796Investigation on oxidative stress of nitric oxide synthase interacting protein from Clonorchis sinensis
Q34974475Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination
Q35757333Involvement of PSMD10, CDK4, and Tumor Suppressors in Development of Intrahepatic Cholangiocarcinoma of Syrian Golden Hamsters Induced by Clonorchis sinensis and N-Nitrosodimethylamine.
Q91991673Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis
Q52586065KSHV induces immunoglobulin rearrangements in mature B lymphocytes.
Q34417383KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
Q33632932Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency
Q40046587Kaposi sarcoma herpesvirus pathogenesis.
Q38865926Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?
Q34470355Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment.
Q35077642Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion
Q36155542Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3
Q31027665Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis
Q35743733Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya
Q33853878LAMPhimerus: A novel LAMP assay for detecting Amphimerus sp. DNA in human stool samples
Q87411147LGALS3 as a prognostic factor for classical Hodgkin's lymphoma
Q33781541Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties
Q34753047Laser capture microdissection shows HPV11 as both a causal and a coincidental infection in cervical cancer specimens with multiple HPV types
Q93064860Latency and lytic replication in Epstein-Barr virus-associated oncogenesis
Q38427810Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure
Q34064235Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma
Q40051371Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population.
Q36395656Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
Q38742752Lineage-specific expansion and loss of tyrosinase genes across platyhelminths and their induction profiles in the carcinogenic oriental liver fluke, Clonorchis sinensis.
Q34209101Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia
Q38975511Liver fluke infection and cholangiocarcinoma: a review
Q47922162Long term variations in erythema effective solar UV at Chilton, UK, from 1991 to 2015.
Q35768850Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort Study
Q42204957Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.
Q44807462Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea
Q47441530Long-term persistence of human papillomavirus in the skin of the glans penis of elderly men above 80 years of age.
Q35163993Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study
Q34763988Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer
Q41620477Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.
Q35907158Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment
Q35669010Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting
Q33698774Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection
Q45393476Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response
Q54393225Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.
Q42197987Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in Chinese patients
Q47239227Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada
Q35974650Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
Q54210992Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.
Q35739512Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection
Q51242022Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
Q26740426Major parasitic diseases of poverty in mainland China: perspectives for better control
Q35665795Male Circumcision and STI Acquisition in Britain: Evidence from a National Probability Sample Survey
Q40072730Male Partners of Infertile Couples with Seminal Infections of Human Papillomavirus Have Impaired Fertility Parameters.
Q34552677Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study
Q35091981Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: the HPV Infection in men (HIM) cohort study
Q37843258Male infertility: a public health issue caused by sexually transmitted pathogens
Q38474214Malignancies after kidney transplantation: a 40-year single-center experience in Korea
Q34205793MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer
Q34358742Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?
Q42197971Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination
Q26999877Metagenomics: A new horizon in cancer research
Q40250983Metformin and the incidence of viral associated cancers in patients with type 2 diabetes.
Q91596225Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women
Q37264251Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.
Q64061295MiRNA-7-5p Inhibits the Growth and Migration of Hepatoma Cells via Cross-Species Regulation of S-Phase Kinase-Associated Protein 2
Q90643326MicroRNA Involvement in Signaling Pathways During Viral Infection
Q42148119Mitochondrial haplogroups and control region polymorphisms in Kaposi's sarcoma patients
Q40382411Mitotic control of human papillomavirus genome-containing cells is regulated by the function of the PDZ-binding motif of the E6 oncoprotein
Q57477151Modeling the Transmission Dynamics of Clonorchiasis in Foshan, China
Q30573204Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada
Q38543395Modification of drug delivery to improve antibiotic targeting to the stomach.
Q52656062Molecular Diagnosis of Felis catus Gammaherpesvirus 1 (FcaGHV1) Infection in Cats of Known Retrovirus Status with and without Lymphoma.
Q61807992Molecular Identification and Phylogenetic Analysis of Nuclear rDNA Sequences of Isolates From Human Fecal Samples in Heilongjiang Province, China
Q30399634Molecular and Structural Characterization of the Tegumental 20.6-kDa Protein in Clonorchis sinensis as a Potential Druggable Target
Q51213476Molecular and structural characteristics of multidrug resistance-associated protein 7 in Chinese liver fluke Clonorchis sinensis.
Q28485368Molecular changes in Opisthorchis viverrini (Southeast Asian liver fluke) during the transition from the juvenile to the adult stage
Q90706883Molecular characteristics and induction profiles of hypoxia-inducible factor-1α and other basic helix-loop-helix and Per-Arnt-Sim domain-containing proteins identified in a carcinogenic liver fluke Clonorchis sinensis
Q39137323Molecular characterization of Clonorchis sinensis tetraspanin 2 extracellular loop 2.
Q34511144Molecular characterization of a tetraspanin from the human liver fluke, Opisthorchis viverrini
Q34394949Molecular characterization of an α-N-acetylgalactosaminidase from Clonorchis sinensis
Q46760732Molecular characterization of voltage-gated calcium channel β-subunits of Clonorchis sinensis
Q27304990Molecular cloning and characterization of taurocyamine kinase from Clonorchis sinensis: a candidate chemotherapeutic target
Q34589241Molecular identification, immunolocalization, and characterization of Clonorchis sinensis calmodulin
Q28070323Molecular mechanisms of HPV mediated neoplastic progression
Q38723429Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.
Q90092792Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma
Q35356381Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays
Q50091385Monitoring the impact of HPV vaccine in males-Considerations and challenges.
Q94234419Mosquitoes, Infectious Diseases, and Cancer: A Connection to Study?
Q37627688Moving forward in HIV-associated cancer.
Q64256422Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology
Q34005902Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England
Q45418018Multidrug resistance-associated protein 4 is a bile transporter of Clonorchis sinensis simulated by in silico docking.
Q37566009Multiple HPV infections in female sex workers in Western Kenya: implications for prophylactic vaccines within this sub population.
Q41710612Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities
Q33761459Multiple recombinant antigens of Clonorchis sinensis for serodiagnosis of human clonorchiasis
Q34793429Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas
Q41689179Multiplex PCR assay for the rapid identification of human papillomavirus genotypes 16, 18, 45, 35, 66, 33, 51, 58, and 31 in clinical samples.
Q31102359Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study
Q92930453Multisite HPV infections in the United States (NHANES 2003-2014): An overview and synthesis
Q38061252Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review
Q37374081NF-κB as a target for oncogenic viruses
Q27347744NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men
Q29248394National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms
Q55080397Natural History and Prognostic Factors of Cholangiocarcinoma With Spinal Metastasis: A 10-Year Single Center Study.
Q60916099Natural Products Mediated Targeting of Virally Infected Cancer
Q90134394Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes
Q92190812Neglected Agent Eminent Disease: Linking Human Helminthic Infection, Inflammation, and Malignancy
Q35985515Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
Q42204836Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes
Q28072213New Biomedical Technologies and Strategies for Prevention of HIV and Other Sexually Transmitted Infections
Q33833622New HPV16 viral biomarkers to understand the progression of cervical lesions towards cancer
Q36313296New insights into cervical cancer screening.
Q36880375New insights into human papillomavirus-associated head and neck squamous cell carcinoma
Q39157266New locality record for Haplorchoides mehrai and possible interactions with Opisthorchis viverrini metacercariae in cyprinid fishes in Northeast Thailand
Q35550810Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females
Q36383927Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits.
Q93079992Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population
Q39252023Nitric oxide-dependent downregulation of BRCA1 expression promotes genetic instability
Q34756499No role for human papillomavirus in esophageal squamous cell carcinoma in China
Q37838813Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era.
Q37720028Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).
Q95923729Novel Forms of Immunomodulation for Cancer Therapy
Q35689082Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types
Q40641957Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignancies.
Q38064057Nucleic acid tests for the detection of alpha human papillomaviruses
Q38216131Nucleic acid-based tissue biomarkers of urologic malignancies
Q44170367Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination
Q36130550Oncogenic Human Papillomavirus Infections in 18- to 24-Year-Old Female Online Daters
Q28743949Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos
Q35250836Opisthorchiasis: an overlooked danger
Q35870248Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte
Q38139812Opportunistic infections due to inflammatory bowel disease therapy
Q37679237Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Q35632240P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1.
Q38607549PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma
Q90616789PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18
Q34991090PDZRN3/LNX3 is a novel target of human papillomavirus type 16 (HPV-16) and HPV-18 E6.
Q92668951Paediatric virology and human papillomaviruses: An update
Q31114737Painless Jaundice Caused by Clonorchis sinensis Infection: A Case Report
Q31161320Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome
Q43227803Papillomaviruses: evolution, Linnaean taxonomy and current nomenclature
Q28067519Parasite Infection, Carcinogenesis and Human Malignancy
Q35397565Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
Q42353369Parasitology should not be abandoned: data from outpatient parasitological testing in Guangdong, China.
Q92498448Partial Characterization of Two Cathepsin D Family Aspartic Peptidases of Clonorchis sinensis
Q45353082Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark
Q34699968Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection.
Q34971664Patterns of human papillomavirus types in multiple infections: an analysis in women and men of the high throughput human papillomavirus monitoring study
Q37834238Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial
Q35981334Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria
Q49461760Performance evaluation of existing immunoassays for Clonorchis sinensis infection in China.
Q64080031Performance of Different Combination Models of High-Risk HPV Genotyping in Triaging Chinese Women With Atypical Squamous Cells of Undetermined Significance
Q84818275Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Q34736619Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing
Q55531260Periodontitis and oral human papillomavirus infection among Hispanic adults.
Q35223393Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer
Q93161915Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry
Q54094196Phylogeny and polymorphism in the long control regions E6, E7, and L1 of HPV Type 56 in women from southwest China.
Q64124680Pilot study of markers for high-grade anal dysplasia in a southern cohort from the Women's Interagency HIV Study (WIHS)
Q92416846Pitfalls of commercially available HPV tests in HPV68a detection
Q39331773Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy
Q37288157Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
Q57089346Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis
Q36427407Population-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest China
Q91909387Positivity and prevalence of human papillomavirus among a large population of women in southeastern China
Q39687528Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study
Q42209186Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening
Q42272904Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program
Q35752872Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand
Q33713347Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers
Q92795372Prevalence and Characteristics of hrHPV Infection among 414,540 Women: A Multicenter Study in Central and Eastern China
Q91922934Prevalence and Distribution of Human Papillomavirus Genotypes Among Women in Kinshasa, The Democratic Republic of the Congo
Q41206464Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India
Q37642113Prevalence and determinants of high-risk human papillomavirus infection in male genital warts
Q58616866Prevalence and distribution of human papillomavirus genotypes among women with high-grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China
Q34074208Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities
Q45323519Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar
Q47598969Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men.
Q36346755Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination
Q35853643Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study
Q37848169Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial
Q36332181Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women
Q34218871Prevalence and risk factors of clonorchiasis among residents of riverside areas in Muju-gun, Jeollabuk-do, Korea
Q33803206Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study
Q50543183Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study.
Q36391662Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva
Q90370251Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study
Q38672420Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general population
Q38974297Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014.
Q28541777Prevalence of HPV 16 and HPV 18 lineages in Galicia, Spain
Q90438579Prevalence of HPV infection among sexually active adolescents and young adults in Brazil: The POP-Brazil Study
Q38944887Prevalence of HPV infection and genotype distribution in women from Africa seeking asylum in Puglia, Italy.
Q40141459Prevalence of Human Papillomavirus Infection in Women in the Autonomous Region of Inner Mongolia: a Population-based Study of a Chinese Ethnic Minority.
Q40116201Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders.
Q38194325Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysis
Q38745367Prevalence of Human Papillomavirus infection among Chilean women from 2012 to 2016.
Q49450258Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Q36257446Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland
Q40862790Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.
Q38944257Prevalence of anogenital HPV infection, related disease and risk factors among HIV-infected men in inner-city Johannesburg, South Africa: baseline findings from a cohort study
Q35768546Prevalence of esophageal squamous papilloma (ESP) and associated cancer in northeastern France
Q45251131Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006.
Q45342236Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women
Q30890822Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial
Q37848950Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation
Q34637954Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay
Q34061684Prevalence of human papillomavirus in adolescent girls before reported sexual debut
Q58280163Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa
Q39475692Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
Q98289239Prevalence of human papillomavirus infection and type distribution among Uyghur females in Xinjiang, northwest China
Q64237318Prevalence of human papillomavirus infection of 65,613 women in East China
Q36865275Prevalence of human papillomavirus types and variants and p16(INK4a) expression in head and neck squamous cells carcinomas in São Paulo, Brazil.
Q47141407Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana
Q38773959Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old).
Q37454986Prevalence of papillomavirus in Brazil: a systematic review protocol
Q35879158Prevalence of type-specific HPV among female university students from northern Brazil
Q54223962Prevalence, incidence and correlates of low risk HPV infection and anogenital warts in a cohort of women living with HIV in Burkina Faso and South Africa.
Q37847698Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands
Q30566680Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)
Q35660411Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women.
Q28255126Preventable exposures associated with human cancers
Q26777318Prevention of infection-related cancers in the WHO Western Pacific Region
Q36736361Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells
Q92647805Primary Infectious Mononucleosis Masquerading as Post-operative Fever in a Young Patient with Cemento-ossifying Fibroma of the Skull Base
Q37912228Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact
Q35203306Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology
Q26825488Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolism
Q36066974Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma
Q54298531Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
Q53245652Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma.
Q90383582Promutagenicity of 8-Chloroguanine, A Major Inflammation-Induced Halogenated DNA Lesion
Q39328580Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2.
Q24202048Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
Q24235373Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
Q54217505Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Q47210863Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.
Q42436631Prospective study of genital human papillomaviruses and nonmelanoma skin cancer
Q33759930Prospects for prevention of HPV-driven oropharynx cancer
Q38819671Proteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection
Q38151763Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancer.
Q34254009Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma
Q42285579Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males
Q60907824Quantification of HPV16 E6/E7 mRNA Spliced Isoforms Viral Load as a Novel Diagnostic Tool for Improving Cervical Cancer Screening
Q35235162Quantitative DNA methylation analysis of candidate genes in cervical cancer
Q35834013RNA Binding Proteins that Control Human Papillomavirus Gene Expression
Q35133671RNA-Seq reveals infection-induced gene expression changes in the snail intermediate host of the carcinogenic liver fluke, Opisthorchis viverrini
Q54974939RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer.
Q35075414Randomization modeling to ascertain clustering patterns of human papillomavirus types detected in cervicovaginal samples in the United States
Q35649341Rapid detection of Opisthorchis viverrini copro-DNA using loop-mediated isothermal amplification (LAMP).
Q40348516Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.
Q34137915Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project
Q35906815Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates
Q38364089Recalcitrant plantar warts during azathioprine therapy for Crohn's disease
Q39034549Recent advances in proteomic applications for schistosomiasis research: potential clinical impact
Q36901045Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011
Q37375588Record linkage to correct under-ascertainment of cancers in HIV cohorts: The Sinikithemba HIV clinic linkage project
Q88813826Recurrence of Genital Infections With 9 Human Papillomavirus (HPV) Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) Among Men in the HPV Infection in Men (HIM) Study
Q37503936Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England
Q38064056Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases
Q57475469Regulation of HPV transcription
Q38087843Regulation of human papillomavirus gene expression by splicing and polyadenylation
Q36370394Relationship between CK19 expression, deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma
Q36584268Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National Population
Q57877211Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies
Q27023448Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment
Q64070590Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand
Q36558983Reproducibility of linear array for human papillomavirus genotyping
Q37995108Review: antibodies to cutaneous human papillomaviruses.
Q37233963Risk Factors for Oral Human Papillomavirus Infection in Healthy Individuals: A Systematic Review and Meta-Analysis
Q33728067Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women
Q35117163Risk factors for high-risk and multi-type Human Papillomavirus infections among women in Ho Chi Minh City, Vietnam: a cross-sectional study.
Q33636055Risk mapping of clonorchiasis in the People's Republic of China: A systematic review and Bayesian geostatistical analysis
Q40412473Risk of Delayed Human Papillomavirus Vaccination in Inner-City Adolescent Women
Q88541577Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials
Q40198005Risk of Onset of Hematological Malignancies in Patients Infected with the Hepatitis B Virus: Results from a Large-Scale Retrospective Cohort Study in China
Q35204230Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention
Q45166430Risk of cancer among workers exposed to trichloroethylene: analysis of three Nordic cohort studies
Q64127196Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study
Q36567658Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection
Q36941977Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities
Q40889610Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study
Q91397020Risk prediction of cervical abnormalities: The value of sociodemographic and lifestyle factors in addition to HPV status
Q57176933Role of Epstein-Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target
Q55338587Role of Pattern Recognition Receptors in KSHV Infection.
Q30299997Role of histological findings and pathologic diagnosis for detection of human papillomavirus infection in men
Q38183454Role of inflammation in HIV-1 disease progression and prognosis
Q38952814Role of socio-cultural and economic factors in cyprinid fish distribution networks and consumption in Lawa Lake region, Northeast Thailand: Novel perspectives on Opisthorchis viverrini transmission dynamics
Q55613070Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.
Q35403714Roles of the immune system in skin cancer.
Q33648719S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition
Q34763466Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers
Q58750202Schistosomiasis
Q34951637Schistosomiasis and cancer in egypt: review
Q33925782Secreted cysteine proteases of the carcinogenic liver fluke, Opisthorchis viverrini: regulation of cathepsin F activation by autocatalysis and trans-processing by cathepsin B
Q38390283Secretomic analysis of extracellular vesicles originating from Polyomavirus-negative and Polyomavirus-positive merkel cell carcinoma cell lines
Q54229599Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.
Q36120539Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis
Q35098354Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter
Q44435078Sequence analysis and characterization of pyruvate kinase from Clonorchis sinensis, a 53.1-kDa homopentamer, implicated immune protective efficacy against clonorchiasis
Q28543067Sequence analysis and molecular characterization of Clonorchis sinensis hexokinase, an unusual trimeric 50-kDa glucose-6-phosphate-sensitive allosteric enzyme
Q33952360Sequence imputation of HPV16 genomes for genetic association studies
Q34602424Sequence variation analysis of HPV-18 isolates in southwest China
Q51416546Sequencing analysis of HPV-other type on an HPV DNA chip.
Q40589093Sequential Acquisition of Anal Human Papillomavirus (HPV) Infection Following Genital Infection Among Men Who Have Sex With Women: The HPV Infection in Men (HIM) Study
Q53430838Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
Q37225559Serum Helicobacter pylori FliD antibody and the risk of gastric cancer
Q57284128Short half-life of HPV16 E6 and E7 mRNAs sensitizes HPV16-positive tonsillar cancer cell line HN26 to DNA-damaging drugs
Q36116209Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly
Q51558156Short-term type-specific HPV persistence and its predictors in an asymptomatic general female population in Zhejiang, China.
Q38370778Signaling pathways in HPV-associated cancers and therapeutic implications.
Q41028798Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression
Q42237432Single human papillomavirus 16 or 52 infection and later cytological findings in Japanese women with NILM or ASC-US.
Q91610417Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein
Q33712114Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men.
Q35463694Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study
Q30238649Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches
Q40877866Space-time clustering of childhood cancers in Switzerland: A nationwide study
Q35680785Specific diagnosis of Opisthorchis viverrini using loop-mediated isothermal amplification (LAMP) targeting parasite microsatellites
Q35336871Specific genotypes of human papillomavirus in 125 high-grade squamous lesions and invasive cervical cancer cases from Congolese women
Q35848186Spectrum of cancer risk among US solid organ transplant recipients
Q34064264Spectrum of cancer risk late after AIDS onset in the United States.
Q39139279Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.
Q39238185Stage-specific expression, immunolocalization of Clonorchis sinensis lysophospholipase and its potential role in hepatic fibrosis
Q47554428Strengthening the case for gender-neutral and the nonavalent HPV vaccine
Q57286493Structural Analysis of an Epitope Candidate of Triosephosphate Isomerase in Opisthorchis viverrini
Q41738958Structural properties of a viral orthologue of cellular CD200 protein: KSHV vOX2.
Q35711258Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway
Q37211860Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana
Q39254514Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens
Q37528882Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs
Q34778995Suppression of Ov-grn-1 encoding granulin of Opisthorchis viverrini inhibits proliferation of biliary epithelial cells
Q42196341Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200.
Q48042695Surveillance and diagnosis of zoonotic foodborne parasites.
Q30884881Surveillance of human papilloma virus using reference laboratory data for the purpose of evaluating vaccine impact
Q39144897Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women
Q35182177Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy
Q53808018Systematic review of racial disparities in human papillomavirus-associated anal dysplasia and anal cancer among men who have sex with men.
Q34239911TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix
Q35795380Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation
Q55439768The DNA damage response activates HPV16 late gene expression at the level of RNA processing.
Q34246710The DNA damage response in viral-induced cellular transformation
Q89577993The Detection and Association of Canine Papillomavirus with Benign and Malignant Skin Lesions in Dogs
Q35850058The Dynamics of Treg/Th17 and the Imbalance of Treg/Th17 in Clonorchis sinensis-Infected Mice
Q36094880The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia
Q90386779The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis
Q97569962The Efficiency of Type-Specific High-Risk Human Papillomavirus Models in the Triage of Women with Atypical Squamous Cells of Undetermined Significance
Q35895297The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy
Q36603938The Incidence of Human Papillomavirus in Tanzanian Adolescent Girls Before Reported Sexual Debut
Q50042026The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis.
Q54980026The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair.
Q33924064The Opisthorchis viverrini genome provides insights into life in the bile duct
Q40366431The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.
Q36173887The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia
Q30574549The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis
Q90469341The Prevalence of HPV Genotypes in Iranian Population: An Update
Q93167108The Role of Beta HPV Types and HPV-Associated Inflammatory Processes in Cutaneous Squamous Cell Carcinoma
Q36029632The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test
Q59133892The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium
Q46142571The Role of Type 2 Diabetes for the Development of Pathogen-Associated Cancers in the Face of the HIV/AIDS Epidemic.
Q53175931The Role of miRNAs in Virus-Mediated Oncogenesis.
Q36243929The Spectrum of Malignancies among Adult HIV Cohort in Poland between 1995 and 2012: A Retrospective Analysis of 288 Cases
Q40270627The VPS4 component of the ESCRT machinery plays an essential role in HPV infectious entry and capsid disassembly
Q38606461The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias
Q92525961The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study
Q39604512The association between cigarette smoking and non-Hodgkin lymphoid neoplasms in a large US cohort study
Q38064068The biology and life-cycle of human papillomaviruses.
Q91841593The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study
Q50544836The burden of HPV associated cancers in two regions in Nigeria 2012-2014.
Q40277632The burden of HPV-related diseases in Italy, 2001-12.
Q64068476The burden of cancers associated with HIV in the South African public health sector, 2004-2014: a record linkage study
Q37095409The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter
Q28546051The chemopotential effect of Annona muricata leaves against azoxymethane-induced colonic aberrant crypt foci in rats and the apoptotic effect of Acetogenin Annomuricin E in HT-29 cells: a bioassay-guided approach
Q35588255The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy
Q40957119The clinical performance of primary HPV screening, primary HPV screening plus cytology cotesting, and cytology alone at a tertiary care hospital
Q89540799The contribution of Latin American research to HPV epidemiology and natural history knowledge
Q27676606The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor
Q38168923The current position and the future perspectives of cervical cancer screening
Q90385101The current status of immunotherapy for cervical cancer
Q28247216The current status of opisthorchiasis and clonorchiasis in the Mekong Basin
Q34788039The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China.
Q57211146The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015
Q34543764The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)
Q96638637The effects of temperature and salinity on the longevity of Opisthorchis viverrini cercariae: a climate change concern
Q34522052The epidemiology of oral HPV infection among a multinational sample of healthy men
Q37202940The evolving definition of carcinogenic human papillomavirus
Q35085603The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis
Q36338867The global cancer epidemic: opportunities for Canada in low- and middle-income countries
Q37008480The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma
Q42238657The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8.
Q36973683The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter
Q33718690The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents
Q51757996The impact of oxidative DNA damage and stress on telomere homeostasis.
Q40364959The impact of sexual behavior on oral HPV infections in young unvaccinated adults
Q54262451The implications of male human papilloma virus infection in couples seeking assisted reproduction technologies.
Q47575035The importance of HPV16 in anal cancer prevention
Q36370353The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study
Q41745967The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy
Q37781463The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer
Q54213834The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer.
Q92684202The landscape of transcription initiation across latent and lytic KSHV genomes
Q89556854The landscape of viral associations in human cancers
Q35074527The metastasis-associated protein-1 gene encodes a host permissive factor for schistosomiasis, a leading global cause of inflammation and cancer
Q36049037The natural history of genital human papillomavirus among HIV-negative men having sex with men and men having sex with women
Q46112576The presence of Merkel cell polyomavirus is associated with deregulated expression of BRAF and Bcl-2 genes in non-small cell lung cancer.
Q41688107The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study
Q90418272The prevalence and genotype distribution of human papillomaviruses among women in Taizhou, China
Q40291505The prevalence of HPV infections in HPV-vaccinated women from the general population.
Q35226408The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM study
Q37056980The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada
Q92217999The prevalence, trends, and geographical distribution of human papillomavirus infection in China: The pooled analysis of 1.7 million women
Q35857515The prevention of infection-associated cancers
Q48152896The rediscovery of H. pylori bacteria in the gastric mucosa by Robin Warren, and implications of this finding for human biology and disease
Q57049696The relationship between anogenital HPV types and incident HIV infection among men who have sex with men and transgender women in Lima, Peru: Findings from a prospective cohort study
Q37951412The role of alcohol dehydrogenase genes in head and neck cancers: a systematic review and meta-analysis of ADH1B and ADH1C.
Q37635138The role of monogamy and duration of heterosexual relationships in human papillomavirus transmission
Q39134383The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18.
Q92382294The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond
Q37359553The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK.
Q37921427The socioeconomic burden of parasitic zoonoses: global trends
Q44698801The state of cancer epidemiology curricula in postgraduate schools worldwide
Q92105680The supernatant of cervical carcinoma cells lines induces a decrease in phosphorylation of STAT-1 and NF-κB transcription factors associated with changes in profiles of cytokines and growth factors in macrophages derived from U937 cells
Q28542937The transcription map of human papillomavirus type 18 during genome replication in U2OS cells
Q35826752Therapeutic Vaccine Strategies against Human Papillomavirus
Q36998862Time to tackle clonorchiasis in China
Q34453484Tobacco consumption and genetic susceptibility to nasopharyngeal carcinoma (NPC) in Thailand
Q41876296Toward a general evolutionary theory of oncogenesis
Q34432763Toward integrated opisthorchiasis control in northeast Thailand: the Lawa project
Q34105253Tracing of the Bile-chemotactic migration of juvenile Clonorchis sinensis in rabbits by PET-CT.
Q93061196Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter
Q33872079Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma
Q64128607Transforming properties of ovine papillomaviruses E6 and E7 oncogenes
Q39356598Transmission between Archaic and Modern Human Ancestors during the Evolution of the Oncogenic Human Papillomavirus 16.
Q55246604Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
Q27312453Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012
Q58709291Trends in Human Papillomavirus-Associated Cancers - United States, 1999-2015
Q35048890Trends in prevalence of clonorchiasis among patients in Heilongjiang province, Northeast China (2009-2012): implications for monitoring and control
Q38824019Triage of high-risk HPV positive women in cervical cancer screening.
Q53302283Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study.
Q39484719Tribendimidine: an alternative anthelmintic for liver flukes?
Q42736270Tumour-infiltrating lymphocytes in the risk stratification of squamous cell carcinoma of the head and neck
Q34986850Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study
Q39040989Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.
Q41655617Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
Q58694440Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case–control study
Q54961163Type-specific human papillomavirus infections and Pap test findings in Inuit and non-Inuit women in Nunavut, Canada.
Q38635196Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran.
Q34604698Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand
Q36631402Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
Q36817074US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines
Q38133612Understanding HPV tests and their appropriate applications
Q37088015Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines
Q34141644Uneven distribution of human papillomavirus 16 in cervical carcinoma in situ and squamous cell carcinoma in older females: A retrospective database study.
Q54406456Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia.
Q21092288Unlocking the transcriptomes of two carcinogenic parasites, Clonorchis sinensis and Opisthorchis viverrini
Q42227506Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology
Q55235014Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic.
Q37085618Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker
Q35036066Updating the PGMY primers and probes for improved detection of HPV68a: validation of version 2 of the PGMY-CHUV assay
Q54252809Updating the epidemiological transition model.
Q59349302Upsetting the Balance: When Viruses Manipulate Cell Polarity Control
Q28539012Urinary estrogen metabolites and self-reported infertility in women infected with Schistosoma haematobium
Q40853468Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening
Q38231273Usefulness, methods and rationale of lymph nodes HPV-DNA investigation in estimating risk of early stage cervical cancer recurrence: a systematic literature review
Q36743080Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018
Q36128894Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction
Q39759678Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study.
Q60919995Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii
Q37558791Validation of an HPV16-mediated carcinogenesis mouse model.
Q92617082Variant sublineages of human papillomavirus type 16 predispose women to persistent infection characterized by a sequence analysis of the E6, L1, and LCR regions
Q40696460Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia
Q30749748Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals
Q44604599Vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer: a meta-analysis involving 2,444 individuals
Q64137499Venom allergen-like protein 28 in Clonorchis sinensis: four epitopes on its surface and the potential role of Cys124 for its conformational stability
Q26770053Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?
Q47571734Viral Oncology: Molecular Biology and Pathogenesis
Q42245758Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer
Q38220140Viral causes of feline lymphoma: retroviruses and beyond
Q51489547Viral colonization in exhaled breath condensate of lung cancer patients: Possible role of EBV and CMV.
Q37681282Viral epigenomes in human tumorigenesis.
Q38870478Viral inhibitors of NKG2D ligands for tumor surveillance.
Q37626453Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women
Q37854816Viral oncogenesis and its role in nonmelanoma skin cancer
Q41925619Viral oncoproteins and ubiquitination: accessing a cellular toolbox for modifying protein function
Q24607716Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A
Q37798008Virus-like particles in vaccine development.
Q34567612Viruses and human cancer: from detection to causality
Q40070529Viruses in cancers among the immunosuppressed.
Q58786822Visual and modular detection of pathogen nucleic acids with enzyme-DNA molecular complexes
Q28678670Water-related parasitic diseases in China
Q35224544What lies within: coinfections and immunity
Q36255302Whole Genome Amplification and Reduced-Representation Genome Sequencing of Schistosoma japonicum Miracidia.
Q22122084Whole-genome sequence of Schistosoma haematobium
Q61811419Whole-genome sequence of the bovine blood fluke Schistosoma bovis supports interspecific hybridization with S. haematobium
Q37811898Why do viruses cause cancer? Highlights of the first century of human tumour virology
Q47429122Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.
Q82646885[Biology of epidermodysplasia verruciformis-associated HPV]
Q85738539[Proven and new methods in the treatment of genital warts]
Q47635199hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner
Q34979227hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
Q58378066p16/Ki-67 dual staining in cervico-vaginal cytology: Correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy
Q35665960p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes

Search more.